These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 8601882)
1. Suppression of intimal hyperplasia in experimental vein grafts by oral l-arginine supplementation and single ex vivo immersion in deferoxamine manganese. Davis MG; Dalen H; Austerheim AM; Gulbrandsen TF; Svendsen E; Hagen PO J Vasc Surg; 1996 Mar; 23(3):410-20. PubMed ID: 8601882 [TBL] [Abstract][Full Text] [Related]
2. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine. Davies MG; Kim JH; Dalen H; Makhoul RG; Svendsen E; Hagen PO Surgery; 1994 Sep; 116(3):557-68. PubMed ID: 8079186 [TBL] [Abstract][Full Text] [Related]
11. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production. Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127 [TBL] [Abstract][Full Text] [Related]
12. Control of the structural and functional consequences of vein graft intimal hyperplasia with a 21-aminosteroid--U74389G. Davies MG; Barber L; Dalen H; Svendsen E; Hagen PO Eur J Vasc Surg; 1994 Jul; 8(4):448-56. PubMed ID: 8088396 [TBL] [Abstract][Full Text] [Related]
13. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition. Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565 [TBL] [Abstract][Full Text] [Related]
14. Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts. Fulton GJ; Davies MG; Barber L; Gray JL; Svendsen E; Hagen PO Eur J Vasc Endovasc Surg; 1998 Apr; 15(4):279-89. PubMed ID: 9610339 [TBL] [Abstract][Full Text] [Related]
16. Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809. Fulton GJ; Davies MG; Barber L; Svendsen E; Hagen PO Surgery; 1998 Feb; 123(2):218-27. PubMed ID: 9481409 [TBL] [Abstract][Full Text] [Related]
18. Influence of perioperative storage solutions on long-term vein graft function and morphology. Davies MG; Hagen PO Ann Vasc Surg; 1994 Mar; 8(2):150-7. PubMed ID: 8198948 [TBL] [Abstract][Full Text] [Related]
19. Postprocedure administration of insulin in canine autologous vein grafting: a potential strategy to attenuate intimal hyperplasia. Zhou N; Yu QJ; Si R; Gao HK; Wang T; Gao F; Wang HC; Bian JF J Cardiovasc Pharmacol; 2010 Oct; 56(4):402-12. PubMed ID: 20625311 [TBL] [Abstract][Full Text] [Related]
20. Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts. Huynh TT; Davies MG; Barber L; Svendsen E; Hagen PO J Surg Res; 1998 Jul; 77(2):104-11. PubMed ID: 9733595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]